Strategic joint venture aims to fast track development and De-Risk Scale-Up
Primient, a leader in plant-based, renewable ingredients, and Synonym, a biomanufacturing infrastructure developer, have entered a strategic partnership to accelerate bioproduct innovation and commercialization, furthering the U.S.’ competitive advantage in the race to bring new, functional and affordable biomaterials to market.
Primient and Synonym will begin work on their first project based at Primient’s Decatur, IL facility. The initial scope of work will focus on re-commissioning and upgrading existing fermentation assets at the site, as well as expanding current capacity and significantly expanding the downstream processing unit.
Once completed, the joint Primient Synonym facility will provide a full suite of wrap-around services for companies using precision fermentation ready to launch new product concepts from the lab to commercial scale.
Complementary expertise, technologies and assets ideally position the partnership to fast-track next generation bioproducts solutions and materials. The partnership seamlessly leverages both Primient’s and Synonym’s expertise and assets, providing the comprehensive infrastructure and support needed to launch new product concepts from the lab to commercial scale.
The project, called iPROOF (Pilot Research Operations Optimization Facility) is partially funded through a U.S. Department of Commerce and Economic Development Administration Phase 2 Tech Hub Grant Award (originally submitted as part of the iFAB Tech Hub Grant submission).
Primient is a 100+ year agri-business pioneer whose breadth and depth in the bioproduct space and manufacturing leadership spans food and industrial ingredients, as well as fermentation process development from feedstock to finished product building a renewable, plant-based future.
Jim Stutelberg, Chief Executive Officer of Primient says “We understand the potential of biobased products and solutions. Our partnership with Synonym will make a material difference for companies trying to break the biobased barrier by providing a scalable, data-led proving ground to grow with support.”
“For precision fermentation sector we use our digital tools, and we understand the steep barriers to entry to bring bioproducts to market. By combining our expertise in development and financing with Primient’s manufacturing excellence and scale, we are enabling customers to transition seamlessly from concept to commercialization” says Edward Shenderovich, Chief Executive Officer of Synonym.
